Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stitz

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Shoulder and Elbow Surgery|December 8, 2022
Fibrillar matrix, Echogenicity, Contour, Thickness, and Suture (FECTS) vs. Global: A comparison of 2 scales developed to assess ultrasound images post rotator cuff repairTiffany G Williams, Lisa M Hackett, Patrick H Lam, et al.
Virology|March 7, 2002
A novel lentivirus vector derived from apathogenic simian immunodeficiency virusJ Stitz, M D Mühlebach, U Blömer, et al.
New Biotechnology|April 5, 2026
HIV-Gag VLP-based Vaccine Purification at manufacturing scale: Combination of Counterflow Centrifugation and Nuclease Treatment as a Key to DNA DepletionM von Elling-Tammen, M Machava, J K Möhle, et al.
Virology|February 9, 2000
MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patientsJ Stitz, S Steidl, H Merget-Millitzer, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Shoulder and Elbow Surgery|December 8, 2022
Fibrillar matrix, Echogenicity, Contour, Thickness, and Suture (FECTS) vs. Global: A comparison of 2 scales developed to assess ultrasound images post rotator cuff repairTiffany G Williams, Lisa M Hackett, Patrick H Lam, et al.
Virology|March 7, 2002
A novel lentivirus vector derived from apathogenic simian immunodeficiency virusJ Stitz, M D Mühlebach, U Blömer, et al.
New Biotechnology|April 5, 2026
HIV-Gag VLP-based Vaccine Purification at manufacturing scale: Combination of Counterflow Centrifugation and Nuclease Treatment as a Key to DNA DepletionM von Elling-Tammen, M Machava, J K Möhle, et al.
Virology|February 9, 2000
MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patientsJ Stitz, S Steidl, H Merget-Millitzer, et al.
Pageof 2